U.S. flag

An official website of the United States government

NM_138694.4(PKHD1):c.6245C>T (p.Thr2082Ile) AND not provided

Germline classification:
Benign (3 submissions)
Last evaluated:
Jul 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000857781.11

Allele description [Variation Report for NM_138694.4(PKHD1):c.6245C>T (p.Thr2082Ile)]

NM_138694.4(PKHD1):c.6245C>T (p.Thr2082Ile)

Gene:
PKHD1:PKHD1 ciliary IPT domain containing fibrocystin/polyductin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p12.2
Genomic location:
Preferred name:
NM_138694.4(PKHD1):c.6245C>T (p.Thr2082Ile)
HGVS:
  • NC_000006.12:g.51912453G>A
  • NG_008753.1:g.180173C>T
  • NM_138694.4:c.6245C>TMANE SELECT
  • NM_170724.3:c.6245C>T
  • NP_619639.3:p.Thr2082Ile
  • NP_733842.2:p.Thr2082Ile
  • NC_000006.11:g.51777251G>A
  • NM_138694.3:c.6245C>T
Protein change:
T2082I
Links:
dbSNP: rs147487242
NCBI 1000 Genomes Browser:
rs147487242
Molecular consequence:
  • NM_138694.4:c.6245C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_170724.3:c.6245C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001154772CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Benign
(Jul 1, 2024)
germlineclinical testing

Citation Link,

SCV001936704GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Benign
(Jul 5, 2018)
germlineclinical testing

Citation Link,

SCV002036450Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV001154772.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

PKHD1: BP4, BS1, BS2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From GeneDx, SCV001936704.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus, SCV002036450.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024